New Delhi: Aurobindo Pharmaceuticals stated on Saturday that its complete net profit Income rose 61% year-on-year to Rs 919 crore within the first quarter ended June 2024, pushed by sturdy sales volume Throughout markets. Headquartered in Hyderabad drug The producer reported a internet revenue of Rs 571 crore within the April-June quarter of the final fiscal yr.
The drugmaker stated in an announcement that working revenue rose to 7,567 crore rupees within the second quarter from 6,851 crore rupees in the identical interval final yr.
“We’re happy with our continued sturdy efficiency within the quarter, with vital income development grow Throughout all our enterprise models,” Aurobindo Pharmaceuticals stated Okay Nithyananda Reddy, Vice Chairman and Managing Director.
Profitability is maintained by enhancing gross margins and working efficiencies in addition to increasing our just lately commercialized vegetation, he added.
“We’re assured in our means to attain our development targets for FY25,” Reddy stated.
